These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21340509)

  • 1. Characterization of dequalinium as a XIAP antagonist that targets the BIR2 domain.
    Orzáez M; Gortat A; Sancho M; Carbajo RJ; Pineda-Lucena A; Palacios-Rodríguez Y; Pérez-Payá E
    Apoptosis; 2011 May; 16(5):460-7. PubMed ID: 21340509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and characterization of bivalent Smac-based peptides as antagonists of XIAP and development and validation of a fluorescence polarization assay for XIAP containing both BIR2 and BIR3 domains.
    Nikolovska-Coleska Z; Meagher JL; Jiang S; Kawamoto SA; Gao W; Yi H; Qin D; Roller PP; Stuckey JA; Wang S
    Anal Biochem; 2008 Mar; 374(1):87-98. PubMed ID: 18023397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BIR2 domain of XIAP plays a marginal role in inhibition of executioner caspases.
    Abhari BA; Davoodi J
    Int J Biol Macromol; 2010 Apr; 46(3):337-41. PubMed ID: 20060411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of benzodiazepinones as selective inhibitors of the X-linked inhibitor of apoptosis protein (XIAP) second baculovirus IAP repeat (BIR2) domain.
    Kester RF; Donnell AF; Lou Y; Remiszewski SW; Lombardo LJ; Chen S; Le NT; Lo J; Moliterni JA; Han X; Hogg JH; Liang W; Michoud C; Rupert KC; Mischke S; Le K; Weisel M; Janson CA; Lukacs CM; Fretland AJ; Hong K; Polonskaia A; Gao L; Li S; Solis DS; Aguilar D; Tardell C; Dvorozniak M; Tannu S; Lee EC; Schutt AD; Goggin B
    J Med Chem; 2013 Oct; 56(20):7788-803. PubMed ID: 24093940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of mammalian mitochondrial proteins that interact with IAPs via N-terminal IAP binding motifs.
    Verhagen AM; Kratina TK; Hawkins CJ; Silke J; Ekert PG; Vaux DL
    Cell Death Differ; 2007 Feb; 14(2):348-57. PubMed ID: 16794601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-penetrating peptide-conjugated XIAP-inhibitory cyclic hexapeptides enter into Jurkat cells and inhibit cell proliferation.
    Sasaki Y; Minamizawa M; Ambo A; Sugawara S; Ogawa Y; Nitta K
    FEBS J; 2008 Dec; 275(23):6011-21. PubMed ID: 19016849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzazepinones and benzoxazepinones as antagonists of inhibitor of apoptosis proteins (IAPs) selective for the second baculovirus IAP repeat (BIR2) domain.
    Donnell AF; Michoud C; Rupert KC; Han X; Aguilar D; Frank KB; Fretland AJ; Gao L; Goggin B; Hogg JH; Hong K; Janson CA; Kester RF; Kong N; Le K; Li S; Liang W; Lombardo LJ; Lou Y; Lukacs CM; Mischke S; Moliterni JA; Polonskaia A; Schutt AD; Solis DS; Specian A; Taylor RT; Weisel M; Remiszewski SW
    J Med Chem; 2013 Oct; 56(20):7772-87. PubMed ID: 24083782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mechanistic insight into SMAC peptide interference with XIAP-Bir2 inhibition of executioner caspases.
    Abhari BA; Davoodi J
    J Mol Biol; 2008 Sep; 381(3):645-54. PubMed ID: 18619610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-fetoprotein antagonizes X-linked inhibitor of apoptosis protein anticaspase activity and disrupts XIAP-caspase interaction.
    Dudich E; Semenkova L; Dudich I; Denesyuk A; Tatulov E; Korpela T
    FEBS J; 2006 Aug; 273(16):3837-49. PubMed ID: 16869888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the X-linked inhibitor of apoptosis protein through 4-substituted azabicyclo[5.3.0]alkane smac mimetics. Structure, activity, and recognition principles.
    Mastrangelo E; Cossu F; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Drago C; Seneci P; Scolastico C; Rizzo V; Bolognesi M
    J Mol Biol; 2008 Dec; 384(3):673-89. PubMed ID: 18851976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP.
    Sun C; Cai M; Gunasekera AH; Meadows RP; Wang H; Chen J; Zhang H; Wu W; Xu N; Ng SC; Fesik SW
    Nature; 1999 Oct; 401(6755):818-22. PubMed ID: 10548111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular interaction between HAX-1 and XIAP inhibits apoptosis.
    Kang YJ; Jang M; Park YK; Kang S; Bae KH; Cho S; Lee CK; Park BC; Chi SW; Park SG
    Biochem Biophys Res Commun; 2010 Mar; 393(4):794-9. PubMed ID: 20171186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for bivalent Smac-mimetics recognition in the IAP protein family.
    Cossu F; Milani M; Mastrangelo E; Vachette P; Servida F; Lecis D; Canevari G; Delia D; Drago C; Rizzo V; Manzoni L; Seneci P; Scolastico C; Bolognesi M
    J Mol Biol; 2009 Sep; 392(3):630-44. PubMed ID: 19393243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico discovery of acylated flavonol monorhamnosides from Eriobotrya japonica as natural, small-molecular weight inhibitors of XIAP BIR3.
    Pfisterer PH; Shen C; Nikolovska-Coleska Z; Schyschka L; Schuster D; Rudy A; Wolber G; Vollmar AM; Rollinger JM; Stuppner H
    Bioorg Med Chem; 2011 Jan; 19(2):1002-9. PubMed ID: 21087868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer.
    Oost TK; Sun C; Armstrong RC; Al-Assaad AS; Betz SF; Deckwerth TL; Ding H; Elmore SW; Meadows RP; Olejniczak ET; Oleksijew A; Oltersdorf T; Rosenberg SH; Shoemaker AR; Tomaselli KJ; Zou H; Fesik SW
    J Med Chem; 2004 Aug; 47(18):4417-26. PubMed ID: 15317454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain.
    Huang Y; Park YC; Rich RL; Segal D; Myszka DG; Wu H
    Cell; 2001 Mar; 104(5):781-90. PubMed ID: 11257231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topotecan triggers apoptosis in p53-deficient cells by forcing degradation of XIAP and survivin thereby activating caspase-3-mediated Bid cleavage.
    Tomicic MT; Christmann M; Kaina B
    J Pharmacol Exp Ther; 2010 Jan; 332(1):316-25. PubMed ID: 19812371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain.
    Liu Z; Sun C; Olejniczak ET; Meadows RP; Betz SF; Oost T; Herrmann J; Wu JC; Fesik SW
    Nature; 2000 Dec 21-28; 408(6815):1004-8. PubMed ID: 11140637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Building homogeneous time-resolved fluorescence resonance energy transfer assays for characterization of bivalent inhibitors of an inhibitor of apoptosis protein target.
    Chaudhry C; Davis J; Zhang Y; Posy S; Lei M; Shen H; Yan C; Devaux B; Zhang L; Blat Y; Metzler W; Borzilleri RM; Talbott RL
    Anal Biochem; 2016 Mar; 497():8-17. PubMed ID: 26743718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonist.
    Griffith TS; Kucaba TA; O'Donnell MA; Burns J; Benetatos C; McKinlay MA; Condon S; Chunduru S
    Apoptosis; 2011 Jan; 16(1):13-26. PubMed ID: 20734142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.